These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
842 related items for PubMed ID: 30711971
1. Clinical Significance of Preoperative Hepatocellular Carcinoma With High Lens culinaris Agglutinin-reactive Fraction of Alpha-Fetoprotein, But Low Alpha-Fetoprotein. Yamao T, Yamashita YI, Imai K, Umezaki N, Tsukamoto M, Kitano Y, Arima K, Miyata T, Nakagawa S, Okabe H, Hayashi H, Chikamoto A, Ishiko T, Baba H. Anticancer Res; 2019 Feb; 39(2):883-889. PubMed ID: 30711971 [Abstract] [Full Text] [Related]
5. Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma. Sassa T, Kumada T, Nakano S, Uematsu T. Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1387-92. PubMed ID: 10654799 [Abstract] [Full Text] [Related]
6. Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations. Morimoto M, Numata K, Nozaki A, Kondo M, Moriya S, Taguri M, Morita S, Konno M, Sugo A, Miyajima E, Maeda S, Tanaka K. Int J Clin Oncol; 2012 Aug; 17(4):373-9. PubMed ID: 21847534 [Abstract] [Full Text] [Related]
7. Scoring system based on tumor markers and Child-Pugh classification for HCC patients who underwent liver resection. Nakagawa S, Hayashi H, Nitta H, Okabe H, Sakamoto K, Higashi T, Kuroki H, Imai K, Hashimoto D, Sakamoto Y, Chikamoto A, Beppu T, Baba H. Anticancer Res; 2015 Apr; 35(4):2157-63. PubMed ID: 25862872 [Abstract] [Full Text] [Related]
9. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Tameda Y, Nakano T. Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630 [Abstract] [Full Text] [Related]
10. Changes in highly sensitive alpha-fetoprotein for the prediction of the outcome in patients with hepatocellular carcinoma after hepatectomy. Toyoda H, Kumada T, Tada T, Ito T, Maeda A, Kaneoka Y, Kagebayashi C, Satomura S. Cancer Med; 2014 Jun; 3(3):643-51. PubMed ID: 24591342 [Abstract] [Full Text] [Related]
13. Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma. Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J. Clin Gastroenterol Hepatol; 2006 Jan; 4(1):111-7. PubMed ID: 16431313 [Abstract] [Full Text] [Related]
15. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy. Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N. Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841 [Abstract] [Full Text] [Related]
18. AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation. Norman JS, Li PJ, Kotwani P, Shui AM, Yao F, Mehta N. J Hepatol; 2023 Dec; 79(6):1469-1477. PubMed ID: 37683735 [Abstract] [Full Text] [Related]
19. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels. Hadziyannis E, Sialevris K, Georgiou A, Koskinas J. Oncol Rep; 2013 Feb; 29(2):835-9. PubMed ID: 23174906 [Abstract] [Full Text] [Related]
20. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders. Wong RJ, Ahmed A, Gish RG. Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665 [Abstract] [Full Text] [Related] Page: [Next] [New Search]